ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P TSX Capped Composite...
42.48
-0.09%
US Tech 100
21,102.40
-0.27%
S&P 500
5,967.84
-0.22%
US Dollar vs CAD
1.37265
-0.04%
Bitcoin
101,953.88
-1.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Quince Therapeutics Inc (QNCX) Share Price

Quince Therapeutics Inc

Quince Therapeutics Inc (QNCX)

NASDAQ
1.30
-0.06
(-4.41%)
Closed June 21 3:00PM
15 min delayed - Upgrade to Realtime
1.30
0.00
(0.00%)
After Hours: 6:46PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.30
Bid
1.30
Ask
1.31
Volume
376,055
1.30 Day's Range 1.43
0.5116 52 Week Range 2.45
Market Cap
59.109M
Previous Close
1.36
Open
1.41
Last Trade
11
@
1.3
Last Trade Time
Financial Volume
US$ 503,150
VWAP
1.338
Average Volume (3m)
343,718
Shares Outstanding
45,468,782
Dividend Yield
-
PE Ratio
-1.56
Earnings Per Share (EPS)
-1.25
Revenue
-
Net Profit
-56.83M

About Quince Therapeutics Inc

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
quincetx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was US$1.36. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 45,468,782 shares outstanding. The market capitalization of Quince Therapeutics is US$61.84 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -1.56.

Ask ADVFN Intelligence (AI)

QNCX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2025
QNCX (-4.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
QNCX (-4.41%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
QNCX (-4.41%)

Form 8-K - Current report
Edgar (US Regulatory)
June 05 2025
QNCX (-4.41%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
QNCX (-4.41%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
QNCX (-4.41%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.18.333333333331.21.451.194289511.38922874CS
40.2119.26605504591.091.450.9252955481.22919347CS
12-0.11-7.801418439721.411.450.72033437181.10076567CS
26-0.46-26.13636363641.762.03970.72032304181.23447004CS
520.6188.40579710140.692.450.51163020521.25386904CS
156-1.27-49.41634241252.572.71710.51164003681.27289871CS
260-49.92-97.46192893451.22121.980.511646859811.68835211CS

QNCX - Frequently Asked Questions (FAQ)

What is the current Quince Therapeutics share price?
The current share price of Quince Therapeutics is US$ 1.30
How many Quince Therapeutics shares are in issue?
Quince Therapeutics has 45,468,782 shares in issue
What is the market cap of Quince Therapeutics?
The market capitalisation of Quince Therapeutics is USD 61.84M
What is the 1 year trading range for Quince Therapeutics share price?
Quince Therapeutics has traded in the range of US$ 0.5116 to US$ 2.45 during the past year
What is the PE ratio of Quince Therapeutics?
The price to earnings ratio of Quince Therapeutics is -1.56
What is the reporting currency for Quince Therapeutics?
Quince Therapeutics reports financial results in USD
What is the latest annual profit for Quince Therapeutics?
The latest annual profit of Quince Therapeutics is USD -56.83M
What is the registered address of Quince Therapeutics?
The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Quince Therapeutics website address?
The website address for Quince Therapeutics is quincetx.com
Which industry sector does Quince Therapeutics operate in?
Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
US$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
US$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
US$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
US$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
US$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
US$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
US$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
US$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
US$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
US$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
US$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
US$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
US$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
US$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12.359
(-0.09%)
193.97M

QNCX Discussion

View Posts
glenn1919 glenn1919 1 week ago
QNCX...........................................................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 month ago
QNCX under $2
👍️0
Monksdream Monksdream 2 months ago
QNCX under $2
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
QNCX BIO BEAST
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
qncx breakout
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
QNCX BREAKING 1.8O KEY
👍️0
glenn1919 glenn1919 7 months ago
QNCX...........................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
QNCX READY TO GO AGAIN
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
QNCX FAST OUT OF THE GATE
👍️0
Laster Laster 8 months ago
Really neat technology AIDE. Novel way of adding a drug into a patients own red blood cell.
Really amazing if it works.
Watching closely here. I think it ran too fast right now without any news.
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
WEEKLY PUSH
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
QNCX AGAIN OFF THAT DIP
👍️0
glenn1919 glenn1919 8 months ago
QNCX.................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 8 months ago
moving back up now.
👍️0
glenn1919 glenn1919 8 months ago
QNCX..........................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 8 months ago
in on the dip. hi t/t.
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
QNCX BIO BEAST
👍️0
TrendTrade2016 TrendTrade2016 8 months ago
QNCX ON THE MOVE
👍️0
Viewmont Viewmont 10 months ago
$QNCX Nice! https://finance.yahoo.com/news/quince-therapeutics-announces-lancet-neurology-110000014.html
👍️0
INFINITI INFINITI 10 months ago
Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

Source
👍️0
Monksdream Monksdream 10 months ago
QNCX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
QNCX
👍️0
Monksdream Monksdream 1 year ago
QNCX under $2
👍️0
AKATITUS AKATITUS 2 years ago
Slow climber
👍️0
Monksdream Monksdream 2 years ago
QNCX under $2
👍️0
AKATITUS AKATITUS 2 years ago
Bought some 1.10s
See what happens
👍️0
knrorrel knrorrel 2 years ago
News https://www.stocktitan.net/news/QNCX/quince-therapeutics-to-acquire-ery-del-sp-a-and-its-phase-3-asset-02yx0yj60e08.html
👍️0
AJ Freely AJ Freely 2 years ago
$QNCX - Up 10% Pre-Market/ Current Price $1.75
To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
👍️0
AJ Freely AJ Freely 2 years ago
$QNCX- Up 26% Pre-Market/ Current Price $1.24
Echo Lake Capital Increase Offer to Acquire Quince Therapeutics
Increases offer to $1.80 per share + CVR to receive 85% of the future net proceeds of Quince as part of the Lighthouse Pharmaceuticals transaction
👍️0
alchemytrader alchemytrader 2 years ago
Happens. Dirty diluting CEOs
👍️0
Backstabbed Backstabbed 2 years ago
Sorry to hear that
👍️0
alchemytrader alchemytrader 2 years ago
not true. i lost my ass trying to swing PSFE HLBZ FUV. took a terrible loss after finally fiving up. Had i held on i would have lost 90-99% of my money.
👍️0
Backstabbed Backstabbed 2 years ago
all about patience. they all run eventually
👍️0
alchemytrader alchemytrader 2 years ago
congrats
👍️0
Backstabbed Backstabbed 2 years ago
$QNCX - added today!
👍️0
Backstabbed Backstabbed 2 years ago
nice. very low PPS here after it hit a high of $1.75 in PM last week
👍️0
Sirpeter Sirpeter 2 years ago
Hi buddy...added it to watch
👍️0
Backstabbed Backstabbed 2 years ago
$QNCX - News out!!! Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
👍️0
tw0122 tw0122 2 years ago
$1.33 running again
👍️0
saj saj 2 years ago
Mid 1.3's nice pop on news
👍️0
makinezmoney makinezmoney 2 years ago
$QNCX: Decent bounce move here..... now 0.74


2 days now back to back....................... it was receding since Summer last ear and now finally going


On WATCH


GO $QNCX
👍️0
cash4 cash4 3 years ago
https://www.otcmarkets.com/filing/html?id=15980132&guid=AKk-kW7ZRh7-B3h
👍️0

Your Recent History

NASDAQ
QNCX
Quince Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads